Improving Atopic Dermatitis Treatment for Adolescents
In adolescents with moderate to severe atopic dermatitis, a Janus kinase (JAK)-selective inhibitor has been shown to maintain high levels of improvement in symptoms and long-term quality of life after 76 weeks with strong evidence of safety, according to …